Stock 7071 AMVIS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Amvis Holdings, Inc.

Equities

7071

JP3128660002

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
2,199 JPY -4.56% Intraday chart for Amvis Holdings, Inc. -1.48% -26.82%
2023 Amvis Holdings, Inc. Reports Earnings Results for the Half Year Ended March 31, 2023 CI
2023 Amvis Holdings, Inc.(TSE:7071) added to FTSE All-World Index CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The company returns high margins, thereby supporting business profitability.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.13 times its estimated earnings per share for the ongoing year.
  • Based on current prices, the company has particularly high valuation levels.
  • The company appears highly valued given the size of its balance sheet.
  • The company is not the most generous with respect to shareholders' compensation.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
AMVIS HOLDINGS, INC. Stock Amvis Holdings, Inc.
-26.82% 1.45B -
ORPEA Stock ORPEA
-23.49% 2.03B
B-
NATIONAL HEALTHCARE CORPORATION Stock National HealthCare Corporation
-1.63% 1.4B -
C+
BROOKDALE SENIOR LIVING INC. Stock Brookdale Senior Living Inc.
+19.76% 1.3B
B
SIENNA SENIOR LIVING INC. Stock Sienna Senior Living Inc.
+14.53% 698M -
B
ARVIDA GROUP LIMITED Stock Arvida Group Limited
-3.64% 460M
B-
MEDITERRANEAN TOWERS LTD. Stock Mediterranean Towers Ltd.
-7.77% 322M - -
HUMANA AB Stock Humana AB
0.00% 122M
B
GOLDEN HOUSE LTD Stock Golden House Ltd
+39.04% 89.02M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 7071 Stock
  4. Ratings Amvis Holdings, Inc.